Gender‐specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: Insights from cardiovascular magnetic resonance
Open Access
- 1 September 2008
- journal article
- Published by Wiley in European Journal of Heart Failure
- Vol. 10 (9), 850-854
- https://doi.org/10.1016/j.ejheart.2008.06.021
Abstract
1 Background: Gender is an independent risk factor for heart failure mortality in hypertrophic cardiomyopathy (HCM). 2 Aims: To explore the interaction between gender, myocardial fibrosis and remodelling in HCM. 3 Methods: We studied 64 HCM patients (28 females, aged 51 ± 16 years) categorized as non‐obstructive (HNCM, n=31) or obstructive (HOCM, n=33) and 60 healthy subjects (31 females, aged 43 ± 14 years). Cine imaging was performed to assess left ventricular volumes and mass. LV remodelling index (LVRI) was calculated. Extension of late gadolinium enhancement (LGE) was quantified. 4 Results: Females in the control group and in the HNCM group had a lower LVRI than males (control: 0.7±0.1 vs. 0.9±0.2 g/ml, pp=ns). Thus the increase in LVRI was more pronounced in females compared to males. LGE was noted in 70% of the patients. No relation was found between the presence or the quantity of myocardial fibrosis and gender in any of the patient subgroups. 5 Conclusion: Our data suggest a disproportionate degree of remodelling in different forms of HCM depending on gender. Gender does not appear to influence the quantity of fibrosis as defined by LGE.Keywords
This publication has 22 references indexed in Scilit:
- Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic studyHeart, 2005
- Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2005
- Hypertrophy, Fibrosis, and Sudden Cardiac Death in Response to Pathological Stimuli in Mice With Mutations in Cardiac Troponin TCirculation, 2004
- Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic CardiomyopathyCirculation, 2004
- The role of gender in the long-term prognosis of patients with myocardial infarction submitted to fibrinolytic treatmentAnnals of Epidemiology, 2004
- American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice GuidelinesJournal of the American College of Cardiology, 2003
- Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonanceJournal of the American College of Cardiology, 2003
- Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel diseaseHeart, 2000
- Gender Differences in the Presentation of Adult Obstructive Hypertrophic Cardiomyopathy With Resting GradientJapanese Circulation Journal, 1999
- Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathyJournal of the American College of Cardiology, 1989